Zofran® taken during pregnancy may increase the risk of birth defects.
According to recent studies, Zofran® (ondansetron), a commonly prescribed medication used to aid morning sickness in pregnant women, may increase the risk of having a baby with a birth defect by as much as 30%. Pregnant women who take Zofran® may give birth to babies with a heart defect, cleft lip, cleft palate or other birth defect. You and your child may be entitled to compensation for the injuries Zofran® caused.
Zofran® (ondansetron) is a prescription anti-nausea medication manufactured by GlaxoSmithKline. It was FDA approved in 1991 for the prevention of nausea and vomiting for patients recovering from surgery or chemotherapy. Zofran® has never been approved by the FDA for the treatment of morning sickness but was often prescribed “off label” to pregnant women. Taking Zofran® during pregnancy, especially the first trimester, has been linked to various birth defects.
Zofran® taken during pregnancy may increase the risk of the following:
- Heart defects
- Heart murmur
- Atrial septal defect
- Cleft lip
- Cleft palate
- Fetal growth restriction
- Kidney defects
- Pregnancy complications
- Other birth defects
Zofran Birth Defect Attorneys
If you or a loved one took Zofran® during pregnancy and gave birth to a baby with a birth defect, call now to speak to a lawyer at our firm. You may be entitled to compensation by filing a lawsuit. Thomas & Wan has handled many defective drug cases nationwide. Our attorneys will fight for you and your child’s rights.